Sign in →

Test ID NMEM Red Blood Cell Membrane Disorders Gene Panel, Next-Generation Sequencing, Varies

Ordering Guidance

Multiple hematology gene panels are available. For more information, see NHHA and Subpanel Comparison Gene List.


Customization of this panel and/or single gene analysis for any gene present on this panel is available. For more information see CGPH / Custom Gene Panel, Hereditary, Next-Generation Sequencing, Varies.


Targeted testing for familial variants (also called site-specific or known variants testing) is available for the genes on this panel. See FMTT / Familial Mutation, Targeted Testing, Varies. To obtain more information about this testing option, call 800-533-1710.

Shipping Instructions

Specimen preferred to arrive within 96 hours of collection.

Necessary Information

1. Metabolic Hematology Next-Generation Sequencing (NGS) Patient Information is required. Testing may proceed without the patient information; however, the information aids in providing a more thorough interpretation. Ordering providers are strongly encouraged to fill out the form and send with the specimen.

2. If form not provided, include the following information with the test request: clinical diagnosis, pertinent clinical history (ie, complete blood cell count results and relevant clinical notes), and differentials based on clinical or morphologic presentation.

Additional Testing Requirements

This test is best interpreted in the context of protein studies and peripheral blood findings. Prior to sending this test, Coombs testing should be negative and consider evaluating a peripheral blood smear. This can be provided by ordering RBCME / Red Blood Cell Membrane Evaluation, Blood. Fill out the information sheet and indicate that a next-generation sequencing test was also ordered. Additionally, providing complete blood cell count data and clinical notes will allow more precise interpretation of results.

Specimen Required

Specimen Type: Whole blood

Patient Preparation: A previous bone marrow transplant from an allogenic donor will interfere with testing. Call 800-533-1710 for instructions for testing patients who have received a bone marrow transplant.


Preferred: Lavender top (EDTA)

Acceptable: Yellow top (ACD)

Specimen Volume: 3 mL

Collection Instructions:

1. Invert several times to mix blood.

2. Send whole blood specimen in original tube. Do not aliquot.

Specimen Stability Information: Ambient (preferred) 4 days/Refrigerated


1. Metabolic Hematology Next-Generation Sequencing (NGS) Patient Information (T816) is required.

2. New York Clients-Informed consent is required. Document on the request form or electronic order that a copy is on file. The following documents are available:

-Informed Consent for Genetic Testing (T576)

-Informed Consent for Genetic Testing (Spanish) (T826)

Useful For

Providing a comprehensive genetic evaluation for patients with a personal or family history suggestive of a red blood cell (RBC) membrane disorder


Second-tier testing for patients in whom previous targeted gene variant analyses were negative for a specific RBC membrane disorder


Establishing a diagnosis of a hereditary RBC membrane disorder, allowing for appropriate management and surveillance of disease features based on the gene involved, especially if splenectomy is a consideration(5)


Identifying variants within genes associated with phenotypic severity, allowing for predictive testing and further genetic counseling

Method Name

Sequence Capture and Targeted Next-Generation Sequencing (NGS) followed by Polymerase Chain Reaction (PCR) and Sanger Sequencing

Reporting Name

RBC Membrane Sequencing, NGS

Specimen Type


Specimen Minimum Volume

1 mL

Specimen Stability Information

Specimen Type Temperature Time Special Container
Varies Varies

Reference Values

An interpretive report will be provided.

Day(s) Performed


Report Available

28 to 42 days

Performing Laboratory

Mayo Clinic Laboratories in Rochester

Test Classification

This test was developed, and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the US Food and Drug Administration.

CPT Code Information



81479 (if appropriate for government payers)

LOINC Code Information

Test ID Test Order Name Order LOINC Value
NMEM RBC Membrane Sequencing, NGS In Process


Result ID Test Result Name Result LOINC Value
619062 Test Description 62364-5
619063 Specimen 31208-2
619064 Source 31208-2
619065 Result Summary 50397-9
619066 Result 82939-0
619067 Interpretation 59465-5
619068 Additional Results In Process
619069 Resources 99622-3
619070 Additional Information 48767-8
619071 Method 85069-3
619072 Genes Analyzed 82939-0
619073 Disclaimer 62364-5
619074 Released By 18771-6